Bayer Capital Corp BV


Bayer is a global company with core competencies in health and agriculture, committed to creating a better world through science, innovation, and sustainable development. The company focuses on improving health, providing high-quality food, and addressing major global challenges with innovative solutions. Bayer's diverse product portfolio includes well-known brands in pharmaceuticals, consumer health, and crop science, contributing to global health and nutrition. The company emphasizes research, innovation, and responsible practices, including the ethical use of animals in research and efforts to develop alternative methods. Bayer is dedicated to sustainability, safety, and transparency, actively engaging in community and environmental initiatives.

Industries

pharmaceutical

Bayer Capital Corp BV

Mijdrecht, Utrecht, The Netherlands, Europe


Products

Fungicide crop-protection formulations

Manufacture and formulation of fungicidal crop-protection products for worldwide distribution.

High-purity pharmaceutical active ingredients (APIs)

Production of high-purity pharmaceutical APIs and intermediates using integrated fermentation and chemical-processing workflows for downstream formulation.

Plant-based medicinal products (phytopharmaceuticals)

Development, manufacture and quality analysis of plant-extract-based medicinal products for self-medication and other indications produced at a dedicated phytopharmaceutical site.


Services

Clinical study operations and registry services

Operational execution of clinical studies and provision of a public trial search platform to connect patients and investigators.

Large-scale API and agrochemical manufacturing

On-site manufacturing of pharmaceutical active ingredients and crop-protection products, combining fermentation and chemical processing for global supply.

Digital agriculture and precision-farming solutions

Deployment and integration of digital farming tools and partnerships to support precision agriculture and farm-management workflows.

Preclinical in vivo study conduct and oversight

Design, conduct and vendor oversight of in vivo safety and efficacy studies required for pharmaceutical and crop-protection development, typically using rodent models, with integrated animal-welfare programs and partner audits.

Pharmacovigilance and adverse event reporting services

Systems for collecting, evaluating and reporting suspected adverse reactions and product quality complaints to health authorities, including public reporting channels and contact options.

Product-supply system implementation and capacity expansion

Operational consulting and internal programs to implement product-supply frameworks and scale manufacturing capacity for increased production volumes.

Expertise Areas

  • Clinical trial management
  • Clinical data transparency and sharing
  • Pharmacovigilance and drug safety reporting
  • Active pharmaceutical ingredient (API) manufacturing
  • Show More (14)

Key Technologies

  • Microbial fermentation
  • Integrated chemical synthesis
  • Genome editing
  • AAV and viral-vector platforms
  • Show More (12)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.